Andrew Stone
Andrew Stone
Latest posts from :
Gathering and acting on insights from digital patient engagement data is...
As big pharma ponders the right sizing of its post-pandemic field forces, can...
Post pandemic, pharma and regulators are both working to accelerate the...
Digital-first engagement is challenging pharma to deliver content on HCPs’...
Faster, better trials, enhanced pharmacoepidemiology and more ambitious...
The FDA is developing guidelines that will help pharma accelerate its adoption...
Spending on digital promotional and educational activity will continue to rise...
Putting patients at the center of trials in Japan using new tools and approaches
With the whole of pharma in various states of ‘hybridisation’, how can MSLs...
There’s a new cross-healthcare initiative to cut medicines waste and lower...